BioSpace News Archive

The Patient-Centered Outcomes Research Institute Board of Governors approved several slates of funding awards totaling about $71.5 million to support 12 new comparative clinical effectiveness research and methods studies.

In the last few years, the DNA sequencing platforms have witnessed huge advancements and it’s been possible because of high-end technological developments on board.

Cytokinetics Inc. announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to present at the virtual Oppenheimer 32nd Annual Healthcare Conference on Tuesday, March 15, 2022 at 11:20 am ET and participate in a fireside chat at the Barclays Global Healthcare Conference on Wednesday, March 16, 2022 at 11:45 am ET at the Loews Miami Beach Hotel in Miami Beach.

Exagen Inc., a leading provider of autoimmune testing solutions, will release financial results for the quarter and year ended December 31, 2021 after the market close on Tuesday, March 22, 2022.

RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, reported financial results for the three months and fiscal year ended December 31, 2021.

Evoke Pharma, Inc., a specialty pharmaceutical company focused primarily on treatments for gastrointestinal diseases, announced its financial results for the fourth quarter and full year ended December 31, 2021, and recent corporate developments.

Paratek Pharmaceuticals, Inc. announced the publication of data from an investigator-initiated study evaluating the activity of NUZYRA® in a dynamic hollow fiber model of Mycobacterium avium complex pulmonary infection.

Anika Therapeutics, Inc., a global joint preservation company in early intervention orthopedics, reported financial results for its fourth quarter and full year ended December 31, 2021.

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced that the company will present at two upcoming investor conferences.

LogicBio® Therapeutics, Inc., a clinical-stage genetic medicine company, announced that president and chief executive officer, Frederic Chereau, will participate in a fireside chat during the Barclays Global Healthcare Conference on March 15, 2022, at 3:20 p.m. ET.